Effect of eptifibatide on coronary flow reserve following coronary stent implantation (an ESPRIT substudy). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy

Am J Cardiol. 2001 Jun 1;87(11):1293-5. doi: 10.1016/s0002-9149(01)01524-7.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Angiography, Digital Subtraction
  • Angioplasty, Balloon, Coronary*
  • Coronary Angiography
  • Coronary Circulation / drug effects*
  • Coronary Disease / diagnostic imaging
  • Coronary Disease / drug therapy*
  • Double-Blind Method
  • Drug Administration Schedule
  • Eptifibatide
  • Female
  • Humans
  • Infusions, Intravenous
  • Male
  • Middle Aged
  • Peptides / administration & dosage*
  • Peptides / adverse effects
  • Platelet Aggregation Inhibitors / administration & dosage*
  • Platelet Aggregation Inhibitors / adverse effects
  • Stents*

Substances

  • Peptides
  • Platelet Aggregation Inhibitors
  • Eptifibatide